Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adrenocortical Carcinoma × lenvatinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 129 Carcinoma, Renal Cell 31 Parkinson Disease 4, Autosomal Dominant Lewy Body 27 Neoplasms 25 Cholangiocarcinoma 24 Endometrial Neoplasms 16 Thyroid Neoplasms 15 Liver Neoplasms 15 Melanoma 13 Biliary Tract Neoplasms 12 Stomach Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Recurrence 8 Ovarian Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Neoplasm Metastasis 7 Breast Neoplasms 7 Uterine Cervical Neoplasms 6 Triple Negative Breast Neoplasms 5 Small Cell Lung Carcinoma 5 Colorectal Neoplasms 5 Pancreatic Neoplasms 4 Kidney Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Transitional Cell 4 Carcinoma 4 Adenocarcinoma 4 Thyroid Carcinoma, Anaplastic 3 Thyroid Cancer, Papillary 3 Solid Tumors 3

Interventions

Mitotane 9 Cisplatin 7 pembrolizumab 6 Specimen Handling 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Etoposide 4 Doxorubicin 4 relacorilant 3 Cytoreduction Surgical Procedures 3 sodium thiosulfate 2 cixutumumab 2 cemiplimab 2 camrelizumab 2 cabozantinib 2 apatinib 2 Trastuzumab 2 Suramin 2 Ipilimumab 2 Cyclophosphamide 2 tipifarnib 1 lenvatinib 1 iodophenyl metomidate 1 gossypol acetic acid 1 fludarabine phosphate 1 entinostat 1 dostarlimab 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05036434 2026-01-23

ACCOMPLISH

National Cancer Center, Korea

Phase 2 Active not recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡